| related words |
| commercializing |
| collaborative |
| study |
| efficacy |
| marketed |
| diagnostic |
| compound |
| therapeutic |
| indication |
| collaboration |
| demonstrate |
| discovery |
| therapy |
| ingredient |
| testing |
| preclinical |
| licensee |
| commercialized |
| viable |
| clearance |
|
| related documents |
| 1131907--3/16/2006--CANCERVAX_CORP |
| 1055726--3/26/2010--INOVIO_BIOMEDICAL_CORP |
| 879169--3/6/2008--INCYTE_CORP |
| 901219--2/26/2008--HUMAN_GENOME_SCIENCES_INC |
| 901219--2/28/2007--HUMAN_GENOME_SCIENCES_INC |
| 1260990--3/9/2007--GTX_INC_/DE/ |
| 819050--3/10/2006--VICAL_INC |
| 943736--3/31/2006--MED-DESIGN_CORP |
| 1060736--3/12/2010--SEATTLE_GENETICS_INC_/WA |
| 1060736--3/13/2009--SEATTLE_GENETICS_INC_/WA |
| 819050--3/3/2008--VICAL_INC |
| 1060736--3/11/2008--SEATTLE_GENETICS_INC_/WA |
| 819050--2/23/2007--VICAL_INC |
| 880771--3/16/2007--SCICLONE_PHARMACEUTICALS_INC |
| 879169--2/28/2007--INCYTE_CORP |
| 879169--3/3/2009--INCYTE_CORP |
| 1060736--3/8/2006--SEATTLE_GENETICS_INC_/WA |
| 1059790--3/8/2006--POZEN_INC_/NC |
| 901219--2/26/2009--HUMAN_GENOME_SCIENCES_INC |
| 879169--3/3/2006--INCYTE_CORP |
|
| related topics |
| {product, candidate, development} |
| {product, liability, claim} |
| {property, intellectual, protect} |
| {customer, product, revenue} |
| {stock, price, operating} |
| {personnel, key, retain} |
| {gas, price, oil} |
| {investment, property, distribution} |
| {financial, litigation, operation} |
| {regulation, government, change} |
| {control, financial, internal} |
| {cost, contract, operation} |
| {system, service, information} |
| {condition, economic, financial} |
| {product, market, service} |
| {interest, director, officer} |
| {operation, natural, condition} |
| {acquisition, growth, future} |
| {cost, regulation, environmental} |
| {competitive, industry, competition} |
|